Transferrin receptor–targeted anti-amyloid antibody enhances brain delivery and mitigates ARIA
Michelle E. Pizzo(Denali Therapeutics (United States)), Y. Joy Yu Zuchero(Denali Therapeutics (United States)), Isabel Becerra(Denali Therapeutics (United States)), Robert G. Thorne(Denali Therapeutics (United States)), Paul H. Weinreb(Biogen (United States)), René Meisner(OncoMed (United States)), Zachary K. Sweeney(Denali Therapeutics (United States)), Lu Shan(Denali Therapeutics (United States)), David Joy(Gladstone Institutes), Claire B. Discenza(Denali Therapeutics (United States)), Nathalie Khoury(Denali Therapeutics (United States)), Stefan Hamann(Biogen (United States)), Timothy Earr(Denali Therapeutics (United States)), Dominic M. Walsh(Biogen (United States)), Joseph Duque(Denali Therapeutics (United States)), Kendra J. Lechtenberg(Stanford Medicine), Jason C. Dugas(Stanford University), Roni Chau(Denali Therapeutics (United States)), Johann Chow(Denali Therapeutics (United States)), Ana C. Amaral(Massachusetts General Hospital), Hilda Solanoy, Wanda Kwan(Denali Therapeutics (United States)), Ming Lye‐Barthel(Biogen (United States)), Jennifer A. Getz(Denali Therapeutics (United States)), Allisa Clemens(Denali Therapeutics (United States)), Pascal E. Sanchez(Denali Therapeutics (United States)), Joseph W. Lewcock(Denali Therapeutics (United States)), Kapil Gadkar(Sea Turtle Conservancy), Sarah L. DeVos(Denali Therapeutics (United States)), Hoang N. Nguyen(Denali Therapeutics (United States)), Edward D. Plowey(Biogen (United States)), Emmanuel S. Ojo(Denali Therapeutics (United States)), Elliot R. Thomsen(Denali Therapeutics (United States)), Ryan J. Watts(Denali Therapeutics (United States)), Vanessa O. Torres(Denali Therapeutics (United States)), Arash Moshkforoush(Denali Therapeutics (United States)), Jennifer Sebalusky(Biogen (United States)), Mark S. Dennis(Denali Therapeutics (United States)), Jordan Abettan(Biogen (United States)), Meredith Calvert(Temasek Life Sciences Laboratory), Darren Chan(University Health Network), Do Jin Kim(Denali Therapeutics (United States)), Wing-sze Leung(Denali Therapeutics (United States)), Raymond K. Tong, Adam P. Silverman(Northwell Health), Laura Fusaro(Denali Therapeutics (United States)), Elysia Roche(Denali Therapeutics (United States)), Thierry Bussiere(Biogen (United States)), Mihalis S. Kariolis(Denali Therapeutics (United States))
Cited by 51
Related Papers
Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index
|Nature Biotechnology|2008|1.4k
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
|Proceedings of the National Academy of Sciences|2013|864
Engaging neuroscience to advance translational research in brain barrier biology
|Nature reviews. Neuroscience|2011|586
Albumin Binding as a General Strategy for Improving the Pharmacokinetics of Proteins
|Journal of Biological Chemistry|2002|496